Bavarian Nordic, with a diverse vaccine portfolio and $340 million in contracts for 2025, offers growth potential for investors despite regulatory risks. See more.
Kennedy has been criticized for making false medical claims. He has also vowed to purge the U.S. Food and Drug Administration ...
Shares of several vaccine makers including Pfizer and Astrazeneca were down Friday morning following the nomination of Robert ...
U.S. stocks suffered their worst loss since election day as the boost from Donald Trump's victory and a Federal Reserve ...
Vaccine stocks react to Robert F. Kennedy Jr.'s HHS nomination. FDA and NIH express concerns over his anti-vaccine views amid ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback